
What to expect from Jay Powell’s Jackson Hole speech
FT News Briefing
00:00
Novo Nordisk's Tumultuous Year and the Rise of Labubus
This chapter examines the challenges faced by Novo Nordisk with its weight loss drugs in the wake of competition from Eli Lilly. Additionally, it explores the unexpected rise of collectible plush toys, Labubus, amid market uncertainties.
Transcript
Play full episode


